A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo

NCT07153666 · clinicaltrials.gov ↗

RECRUITING

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Vitiligo

Interventions

DRUG: Ruxolitinib 1.5% Cream BID

Sponsor

Peking University Third Hospital